penicillamine has been researched along with Facial Hemiatrophy in 1 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Facial Hemiatrophy: A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldenstein-Schainberg, C | 1 |
| Pereira, RM | 1 |
| Gusukuma, MC | 1 |
| Messina, WC | 1 |
| Cossermelli, W | 1 |
1 other study available for penicillamine and Facial Hemiatrophy
| Article | Year |
|---|---|
Childhood linear scleroderma "en coup de sabre" with uveitis.
Topics: Autoantibodies; Azathioprine; Child; Diagnosis, Differential; Facial Hemiatrophy; Humans; Male; Peni | 1990 |